共 50 条
- [1] Randomized, controlled trial with interferon-alpha plus ribavirin with and without amantadine sulphate in patients with chronic hepatitis C relapsing after previous successful antiviral treatmentHEPATOLOGY, 2002, 36 (04) : 579A - 579ATeuber, GPascu, MBerg, TLafrenz, MWeidenbach, HSchölmerich, JWielzke-Braun, PArnold, RPausch, JLock, GJunge, UMusch, EZankel, MHopf, UZeuzem, S
- [2] Randomized, controlled trial with interferon-alfa plus ribavirin with and without amantadine sulphate in patients with chronic hepatitis C relapsing after primary successful antiviral treatment.HEPATOLOGY, 2001, 34 (04) : 579A - 579ATeuber, GMaria, PLafrenz, MWeidenbach, HSchoelmerich, JWietzke-Braun, PArnold, RPausch, JLock, GJunge, UMusch, EZeuzem, S
- [3] Clinical trial: a randomized trial of pegylated-interferon-α-2a plus ribavirin with or without amantadine in treatment-naive or relapsing chronic hepatitis C patientsALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (04) : 352 - 363Langlet, P.D'Heygere, F.Henrion, J.Adler, M.Delwaide, J.Van Vlierberghe, H.Mulkay, J. P.Lasser, L.Brenard, R.Horsmans, Y.Michielsen, P.Laureys, A.Nevens, F.
- [4] Effects of alpha interferon induction plus ribavirin with or without amantadine in the treatment of interferon nonresponsive chronic hepatitis C: a randomised trialGUT, 2003, 52 (05) : 701 - 705Adinolfi, LEUtili, RTonziello, ARuggiero, G
- [5] Randomized, controlled trial with interferon-alpha (IFN-alpha) combined with ribavirin with and without amantadine sulfate in primary IFN-alpha nonresponsive patients with chronic hepatitis CJOURNAL OF HEPATOLOGY, 2001, 34 : 23 - 23Teuber, GBerg, TLafrenz, MWeidenbach, HSchoelmerich, JWietzke-Braun, PPausch, JArnold, RLock, GHopf, UZeuzem, S
- [6] Triple therapy with amantadine sulphate plus ribavirin and interferon-alpha in previously untreated patients with chronic hepatitis C: Results of a double-blind, placebo-controlled trialJOURNAL OF HEPATOLOGY, 2002, 36 : 3 - 3Berg, TKronenberger, BHinrichsen, HGerlach, TBuggisch, PSpengler, UGoeser, TPape, GHopf, UZeuzem, S
- [7] A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis CJOURNAL OF GASTROENTEROLOGY, 2007, 42 (05) : 362 - 367Gramenzi, AnnagiuliaAndreone, PietroCursaro, CarmelaVerucchi, GabriellaBoccia, SergioGiacomoni, Pier LuigiGalli, SilviaFurlini, GiulianoBiselli, MaurizioLorenzini, StefaniaAttard, LucianoBonvicini, FiorenzaBernardi, Mauro
- [8] A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis CJournal of Gastroenterology, 2007, 42 : 362 - 367Annagiulia GramenziPietro AndreoneCarmela CursaroGabriella VerucchiSergio BocciaPier Luigi GiacomoniSilvia GalliGiuliano FurliniMaurizio BiselliStefania LorenziniLuciano AttardFiorenza BonviciniMauro Bernardi
- [9] A prospective, randomized controlled trial of high dose interferon-alpha plus ribavirin in interferon-nonresponders with chronic hepatitis C.HEPATOLOGY, 1997, 26 (04) : 1148 - 1148Ferenci, PStauber, RHackl, WDatz, CGschwantler, WSteindl, P
- [10] A randomised trial of pegylated interferon alpha-2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirinJOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S148 - S148Ciancio, A.Picciotto, A.Giordanino, C.Smedile, A.Tabone, M.Manca, A.Marenco, G.Garbagnoli, P.Andreoni, M.Cariti, G.Calleri, G.Sartori, M.Cusumano, S.Grasso, A.Basso, M.Rizzetto, M.Saracco, G.